Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6859)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2014; 20(45): 17141-17147 [PMID: 25493028 DOI: 10.3748/wjg.v20.i45.17141] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17141.htm |
| Number | Citing Articles |
| 1 |
Giuseppe Sena, Daniele Paglione, Gaetano Gallo, Marta Goglia, Mariasara Osso, Bruno Nardo. Surgical Resection of a Recurrent Hepatocellular Carcinoma with Portal Vein Thrombosis: Is It a Good Treatment Option? A Case Report and Systematic Review of the Literature. Journal of Clinical Medicine 2022; 11(18): 5287 doi: 10.3390/jcm11185287
|
| 2 |
Xiu-Ping Zhang, Zhen-Hua Chen, Teng-Fei Zhou, Le-Qun Li, Min-Shan Chen, Tian-Fu Wen, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study. European Journal of Surgical Oncology 2019; 45(9): 1644 doi: 10.1016/j.ejso.2019.03.043
|
| 3 |
Jiang Li, Yu Hou, Xiao-Bei Cai, Bin Liu. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(15): 4034-4040 doi: 10.3748/wjg.v22.i15.4034
|
| 4 |
Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3545-5
|
| 5 |
Yanfang Zhang, Xuezhong Lei, Liangliang Xu, Xiaoju Lv, Mingqing Xu, Hong Tang. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01682-0
|
| 6 |
Lei Huo, Wenxin Wei, Zhenlin Yan, Zhengqing Lei, Yanting Xie, Renyan Gong, Shengyu Huang, Ningyang Jia, Yong Xia. Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0285-z
|
| 7 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
|
| 8 |
Kazuhiko Sakamoto, Hiroaki Nagano. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatology Research 2017; 47(10): 957 doi: 10.1111/hepr.12923
|
| 9 |
Sae Jung Na, Jin Kyoung Oh, Seung Hyup Hyun, Jeong Won Lee, Il Ki Hong, Bong-Il Song, Tae-Sung Kim, Jae Seon Eo, Sung Won Lee, Ie Ryung Yoo, Yong An Chung, Mijin Yun. 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study. Journal of Nuclear Medicine 2017; 58(5): 730 doi: 10.2967/jnumed.116.182022
|
| 10 |
Hai-Hong Ye, Jia-Zhou Ye, Zhi-Bo Xie, Yu-Chong Peng, Jie Chen, Liang Ma, Tao Bai, Jun-Ze Chen, Zhan Lu, Hong-Gui Qin, Bang-De Xiang, Le-Qun Li. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein. World Journal of Gastroenterology 2016; 22(13): 3632-3643 doi: 10.3748/wjg.v22.i13.3632
|
| 11 |
佳敏 马. Progress in the Treatment of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus. Advances in Clinical Medicine 2021; 11(12): 6018 doi: 10.12677/ACM.2021.1112892
|
| 12 |
Brian I. Carr, Vito Guerra. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis. Digestive Diseases and Sciences 2016; 61(3): 937 doi: 10.1007/s10620-015-3922-3
|
| 13 |
Xiu‐Ping Zhang, Yu‐Zhen Gao, Zhen‐Hua Chen, Min‐Shan Chen, Le‐Qun Li, Tian‐Fu Wen, Li Xu, Kang Wang, Zong‐Tao Chai, Wei‐Xing Guo, Jie Shi, Dong Xie, Meng‐Chao Wu, Wan Yee Lau, Shu‐Qun Cheng. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study. Hepatology 2019; 69(5): 2076 doi: 10.1002/hep.30490
|
| 14 |
Luyun Yuan, Jinkai Feng, Yuqing Zhang, Chongde Lu, Liu Xu, Chao Liang, Zonghan Liu, Feifei Mao, Yanjun Xiang, Weijun Wang, Kang Wang, Shuqun Cheng. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study. European Journal of Surgical Oncology 2023; 49(7): 1226 doi: 10.1016/j.ejso.2023.01.020
|
| 15 |
Yan‐Yan Wang, Jian‐Hong Zhong, Hong‐Gui Qin, Le‐Qun Li. Comment on: Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. Journal of Surgical Oncology 2015; 112(8): 907 doi: 10.1002/jso.24066
|
| 16 |
G.K. Glantzounis, A. Paliouras, M.-C. Stylianidi, H. Milionis, P. Tzimas, D. Roukos, G. Pentheroudakis, E. Felekouras. The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. European Journal of Surgical Oncology 2018; 44(2): 195 doi: 10.1016/j.ejso.2017.11.022
|
| 17 |
Jing Li, Liang Huang, Jianjun Yan, Maixuan Qiu, Yiqun Yan. Liver resection for hepatocellular carcinoma: personal experiences in a series of 1330 consecutive cases in China. ANZ Journal of Surgery 2018; 88(10) doi: 10.1111/ans.14381
|
| 18 |
Zun-Yi Zhang, Ke-Shuai Dong, Er-Lei Zhang, Li-Wei Zhang, Xiao-Ping Chen, Han-Hua Dong. Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis. Medicine 2019; 98(50): e18362 doi: 10.1097/MD.0000000000018362
|
| 19 |
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clinical 2016; 6: 125 doi: 10.1016/j.bbacli.2016.10.001
|
| 20 |
Jack P. Silva, Nicholas G. Berger, Susan Tsai, Kathleen K. Christians, Callisia N. Clarke, Harveshp Mogal, Sarah White, William Rilling, T. Clark Gamblin. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB 2017; 19(8): 659 doi: 10.1016/j.hpb.2017.04.016
|
| 21 |
Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3895-z
|
| 22 |
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
|
| 23 |
Bao-Hong Yuan, Wei-Ping Yuan, Ru-Hong Li, Bang-De Xiang, Wen Feng Gong, Le-Qun Li, Jian-Hong Zhong. Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma. Tumor Biology 2016; 37(2): 2435 doi: 10.1007/s13277-015-4091-x
|
| 24 |
Lei Liang, Ting-Hao Chen, Chao Li, Hao Xing, Jun Han, Ming-Da Wang, Han Zhang, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus. HPB 2018; 20(12): 1119 doi: 10.1016/j.hpb.2018.06.1804
|
| 25 |
Aline Mähringer‐Kunz, Verena Steinle, Christoph Düber, Arndt Weinmann, Sandra Koch, Irene Schmidtmann, Sebastian Schotten, Jan B. Hinrichs, Dirk Graafen, Daniel Pinto dos Santos, Peter R. Galle, Roman Kloeckner. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?. Liver International 2019; 39(2): 324 doi: 10.1111/liv.13988
|
| 26 |
Yu Zhang, Jun-Li Wu, Le-Qun Li. Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus. Annals of Hepatology 2022; 27(1): 100552 doi: 10.1016/j.aohep.2021.100552
|
| 27 |
Xiao‐Long Li, Wei‐Xing Guo, Xiao‐Dong Hong, Liang Yang, Kang Wang, Jie Shi, Nan Li, Meng‐Chao Wu, Shu‐Qun Cheng. Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis. Hepatology Research 2016; 46(11): 1088 doi: 10.1111/hepr.12657
|
| 28 |
Jeong Il Yu, Hee Chul Park. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2016; 22(30): 6851-6863 doi: 10.3748/wjg.v22.i30.6851
|
| 29 |
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget 2016; 7(38): 61378 doi: 10.18632/oncotarget.11358
|
| 30 |
Keera Kang, Sung Kyu Song, Chul-Woon Chung, Yongkeun Park. Value of surgical resection compared to transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis of hazard ratios from five observational studies. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(3): 243 doi: 10.14701/ahbps.2020.24.3.243
|
| 31 |
Zong-Tao Chai, Xiu-Ping Zhang, Jian-Yang Ao, Xiao-Dong Zhu, Meng-Chao Wu, Wan Yee Lau, Hui-Chuan Sun, Shu-Qun Cheng. AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.650963
|
| 32 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
| 33 |
Xingshun Qi, Diya Wang, Chunping Su, Hongyu Li, Xiaozhong Guo. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget 2015; 6(21): 18715 doi: 10.18632/oncotarget.4134
|